Targeted News Service

University of Cincinnati: Exploring GLP-1 Drugs for Alzheimer's Prevention
March 31, 2026

CINCINNATI, Ohio, March 31 -- The University of Cincinnati posted the following news:

* * *

Exploring GLP-1 drugs for Alzheimer's prevention

UC study uses anonymous real-world patient data to rate safety, effectiveness, affordability

By Tim Tedeschi, 513/556-5694, tedesctd@ucmail.uc.edu

Glucagon-like peptide-1 (GLP-1) drugs have surged in popularity due to their effect on the digestive system, helping patients manage Type 2 di . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form